AutoGenomics Launches INFINITI® H. Pylori Assay for Detection of Helicobacter Pylori and Mutations at 2142g & 2143g That Are Associated with Antibiotic Resistance
AutoGenomics Inc., a molecular diagnostics company offering an innovative and proprietary technology platform for all clinical laboratories announced today the commercial availability of INFINITI® H. pylori Assay. The assay is designed to detect Helicobacter pylori and mutations at 2142G &... - April 09, 2017
AutoGenomics to Introduce INFINITI® SMART – Sample-to-Result NextGen Automation Platform – at AACC 2015
AutoGenomics, Inc., a leader in providing automated molecular testing solutions to clinical laboratories, announced today that it will showcase its “Sample-to-Result” NextGen automation platform – INFINITI® SMART – at the American Association for Clinical Chemistry... - July 24, 2015
AutoGenomics Launches a Test for Genotyping Hepatitis C Virus on Its Microarray-Based INFINITI® Systems
AutoGenomics launches a Hepatitis C Virus Genotyping test in the US and the global market. - April 30, 2015
Press Releases 1 - 3 of 3